An observational study in Stroke, sponsored by University of Salamanca. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-30.
Sponsored by University of Salamanca · Observational
The aim of this study is to adapt and validate the Spanish version of the Brief-BESTest in stroke patients
Balance disorder is a major risk factor for falls. The population that has suffered a cerebrovascular accident (CVA) or stroke has balance disorders. Over the last few years the assessment of balance has taken on special importance, carrying out the development, adaptation and validation of various tools that assess it.
The Brief-BESTest has 6 items, it has demonstrated comparable reliability to the Mini-BESTest and potentially superior sensitivity. This version represents all dimensions based on the original BESTest theory.
The purpose is to adapt and validate the Spanish version of the Brief-BESTest in stroke patients in order to have a brief tool, appropriate to the clinical environment and to the characteristics and limitations of these patients.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's enrollment of 44 is below the median of 160 across 1,692 observational studies indexed under Stroke.
Browse Stroke studies →University of Salamanca is the lead sponsor of 110 studies on the registry; 48 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Stroke patients
Exclusion Criteria:
Instrument validation in stroke patients
Diagnostic Test: Spanish version of the Brief-BESTest in stroke patients
Adaptation and validation of the Spanish version of the Brief-BESTest in stroke Patients
BESTest
Time frame: Baseline
Mini-BESTest
Time frame: Baseline
Berg Balance Test
Time frame: Baseline
Time Up and Go Test
Time frame: Baseline
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Salamanca